Afrezza

Clearing Up the Uncertainty Around MannKind’s Afrezza
Seeking Alpha
Wed, 12/8/10 - 10:01 am
MannKind
inhaled insulin
Afrezza
Is MannKind a Bad News Buy?
Motley Fool
Sat, 11/6/10 - 12:59 pm
MannKind
inhaled insulin
Afrezza
diabetes
MannKind Falls After Lawsuit Alleges Unlawful Clinical Trial Conduct
Bloomberg
Thu, 11/4/10 - 10:00 pm
MannKind
lawsuits
diabetes
fraud
Afrezza
MannKind Accused of Data Fraud Coverup
TheStreet.com
Thu, 11/4/10 - 11:33 am
MannKind
fraud
Afrezza
inhaled insulin
diabetes
[video] For All MannKind?
CNBC
Fri, 10/15/10 - 10:38 am
inhaled insulin
MannKind
Afrezza
FDA's Top Q4 Blockbuster Drug Decisions
Fierce Biotech
Tue, 10/12/10 - 11:26 am
Linjeta
Biodel
Afrezza
MannKind
FDA
Benlysta
Human Genome
GSK
Bydureon
Eli Lilly
Amylin
Alkermes
Brilinta
AstraZeneca
Pradaxa
Boehringer Ingelheim
Qnexa
Vivus
Contrave
Orexigen
ipilimumab
Bristol-Myers Squibb
Merck KGaA
cladribine
Biodel's Linjeta Should Overcome the Usual FDA Approval Hurdles
Seeking Alpha
Wed, 09/15/10 - 10:46 am
FDA
Biodel
Linjeta
diabetes
MannKind
inhaled insulin
Afrezza
insulin injectables
MannKind / Seaside 88: Not Good News for Investors
Seeking Alpha
Thu, 08/12/10 - 11:33 am
MannKind
diabetes
Afrezza
Seaside 88
financing
Technically, MannKind Is a Buy
Motley Fool
Wed, 08/11/10 - 11:03 am
diabetes
inhaled insulin
MannKind
Afrezza
Will MannKind's Afrezza Succeed Where Pfizer's Exubera Failed?
Seeking Alpha
Mon, 07/26/10 - 11:13 am
Pfizer
MannKind
Afrezza
diabetes
inhaled insulin
Good News for MannKind
Yahoo/Zacks
Sat, 07/24/10 - 03:05 pm
Afrezza
MannKind
inhaled insulin
diabetes
FDA Accepts AFREZZA Complete Response Resubmission and Sets Target Action Date
Yahoo
Tue, 07/20/10 - 09:24 am
FDA
Afrezza
inhaled insulin
diabetes
What’s Up with MannKind?
Barron's
Wed, 07/14/10 - 04:32 pm
MannKind
Afrezza
diabetes
inhaled insulin
Mannkind: Rodman & Renshaw Reiterates Buy on Afrezza Data
Barron's
Thu, 07/1/10 - 08:41 am
MannKind
Afrezza
diabetes
inhaled insulin
Diabetes Drug Development Pops and Drops
Motley Fool
Wed, 06/30/10 - 09:57 am
diabetes
Orexigen
Contrave
Avandia
GSK
Merck
Eli Lilly
Amylin
Novo Nordisk
JNJ
MannKind
Afrezza
Mannkind Falls Following Afrezza Presentation; Hapoalim Reiterates Sell
Barron's
Mon, 06/28/10 - 02:53 pm
MannKind
Afrezza
diabetes
inhaled insulin
Hapoalim
AFREZZA Suppresses Endogenous Glucose Production More Rapidly Than Currently Available Insulin Therapy
Yahoo/BusinessWire
Sun, 06/27/10 - 10:52 am
Afrezza
MannKind
diabetes
type 2 diabetes
MannKind Bear Analysts Strike Again
Seeking Alpha
Wed, 06/16/10 - 08:23 am
MannKind
Afrezza
Eli Lilly
inhaled insulin
diabetes
Another Step Back For MannKind?
Pharmalot
Fri, 06/11/10 - 10:18 am
MannKind
inhaled insulin
diabetes
Afrezza
MannKind Jumps as Inhaled Insulin Shows Superior Data
Barron's
Thu, 06/10/10 - 01:00 pm
MannKind
inhaled insulin
Afrezza
diabetes

Pages